Rigel Pharmaceuticals (RIGL) Operating Income (2010 - 2026)
Rigel Pharmaceuticals (RIGL) posted Operating Income of $23.58 million for Q2 2026, down 61.4% from $61.1 million a year earlier but up 98.4% from the prior quarter.
Powered by 
Analysis
Rigel Pharmaceuticals (RIGL) Operating Income (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Operating Income at Rigel Pharmaceuticals was $87.05 million, down 16.8% year-over-year; for FY2025, it was $125.47 million, up 418.6% from FY2024.
- In prior years, Rigel Pharmaceuticals' Operating Income was $24.19 million in FY2024, -$20.49 million in FY2023, -$55.55 million in FY2022 and -$12.5 million in FY2021.
- Quarterly Operating Income has run from a low of -$26.26 million in Q1 2022 to a high of $61.1 million in Q2 2025 over five years.
- On a year-over-year basis, Operating Income increased in three of the last five quarters, with growth averaging 164.0%.
- According to Business Quant data, Operating Income for the three prior quarters was $11.89 million (Q1 2026), $23.17 million (Q4 2025) and $28.42 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 7.14 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 6.43 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -584.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.75 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 3.16 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 3.51 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.39 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 4.27 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.25 Bn |
| 10 | Rigel Pharmaceuticals | 922.04 Mn | 387.93 Mn | 70.18 Mn | 23.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.58 Mn |
| Mar 31, 2026 | 11.89 Mn |
| Dec 31, 2025 | 23.17 Mn |
| Sep 30, 2025 | 28.42 Mn |
| Jun 30, 2025 | 61.10 Mn |
| Mar 31, 2025 | 12.77 Mn |
| Dec 31, 2024 | 16.66 Mn |
| Sep 30, 2024 | 14.06 Mn |
| Jun 30, 2024 | 447,000.00 |
| Mar 31, 2024 | -6.97 Mn |
| Dec 31, 2023 | 1.97 Mn |
| Sep 30, 2023 | -4.47 Mn |
| Jun 30, 2023 | -5.27 Mn |
| Mar 31, 2023 | -12.73 Mn |
| Dec 31, 2022 | 2.08 Mn |
| Sep 30, 2022 | -18.40 Mn |
| Jun 30, 2022 | -12.97 Mn |
| Mar 31, 2022 | -26.26 Mn |
| Dec 31, 2021 | -21.42 Mn |
| Sep 30, 2021 | -19.79 Mn |
API Access
Rigel Pharmaceuticals Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=RIGL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "RIGL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=RIGL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();